Leerink Sees Priory Probe as Marginal Headwind for Acadia Healthcare (ACHC); Affirms at 'Outperform'
Tweet Send to a Friend
Leerink affirms Acadia Healthcare (Nasdaq: ACHC) at Outperform with a price target of $90 after the UK Competitive Market Authority ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
